gefitinib 中文意思是什麼
gefitinib
解釋
吉非替尼-
Gefitinib has a more favorable tolerability profile and less adverse effect than traditional chemotherapy agents in the treatment of tumor since it aim directly at tumour cells
與傳統化療藥物相比，吉非替尼具有瞄準特定的分子靶點、不良反應小和特異性強等優點。 -
Howeer, mutant abcg2 can be less efficient at pushing gefitinib out of cells in the intestine, the researchers noted. a buildup of drug within these cells can cause diarrhea
研究人員指出，突變的abcg2降低了腸道細胞「泵出」的功能，使得細胞內的藥物逐漸累積從而導致腹瀉。 -
Yang ch, shih jy, chen kc. survival outcome and predictors of gefitinib antitumor activity in east asian chemonaive patients with advanced nonsmall cell lung cancer [ j ]. cancer, 2006, 107 ( 8 ) : 1873
劉坤，趙金奇，王羽豐，等.長春瑞濱加草酸鉑或順鉑治療晚期肺腺癌的比較[ j ] .實用癌癥雜志， 2006 ， 21 （ 3 ） : 283 -
Gefitinib ( iressa, zd1839 ), a specific tyrosine kinase inhibitor that targets the epidermal growth factor receptor ( egfr ), is a novel molecular - targeting antineoplastic agent
摘要吉非替尼是一種新型的分子靶向抗癌藥物，它選擇性抑製表皮生長因子受體酪氨酸激酶而發揮作用。 -
Clinical study of gefitinib combined with aidi injection in treatment of non - small - cell lung cancer
吉非替尼聯合艾迪治療老年非小細胞肺癌的臨床研究 -
In addition to its meaningful antitumor activity, gefitinib also provides improvements in quality of life and lung cancer - related symptoms in a large numbers of clinical studies
大規模臨床研究顯示，吉非替尼對于晚期非小細胞肺癌具有明顯的抗腫瘤活性，並能較快改善患者的臨床癥狀，提高晚期生活質量。 -
Complete regression by gefitinib as the first line treatment for advanced lung adenocarcinoma : a case report
吉非替尼一線治療晚期肺腺癌完全緩解1例
分享友人